Patents by Inventor Kenya Prince-Cohane

Kenya Prince-Cohane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170043005
    Abstract: The present invention provides novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. The present invention further provides methods of using the antigens to elicit immune responses (e.g., T cell-mediated and/or B cell-mediated immune responses). The present invention provides methods of prophylaxis and/or treatment of chlamydia-mediated diseases comprising administering an immunogenic composition including one or more of the novel antigens described herein.
    Type: Application
    Filed: March 24, 2016
    Publication date: February 16, 2017
    Inventors: Jessica Baker Flechtner, Kenya Prince Cohane, Todd Gierahn, Alexander Yao-Hsein Lee, George Rainer Siber
  • Publication number: 20120135025
    Abstract: The present invention provides novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. The present invention further provides methods of using the antigens to elicit immune responses (e.g., T cell-mediated and/or B cell-mediated immune responses). The present invention provides methods of prophylaxis and/or treatment of chlamydia-mediated diseases comprising administering an immunogenic composition including one or more of the novel antigens described herein.
    Type: Application
    Filed: October 20, 2011
    Publication date: May 31, 2012
    Applicant: GENOCEA BIOSCIENCES, INC.
    Inventors: Jessica Baker Flechtner, Kenya Prince Cohane, Todd Gierahn, Alexander Yao-Hsien Lee, George Rainer Siber
  • Patent number: 7309491
    Abstract: Hybrid antigens comprising at least one antigenic domain, at least one heat shock protein binding domain, and at least one improved peptide linker there between are described which are useful for the induction of an immune response to the antigenic domain when administered alone or in a complex with at least one heat shock protein. The hybrid antigens and complexes can be used to treat infectious diseases and cancers that express an antigen of the antigenic domain.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: December 18, 2007
    Assignee: Antigenics Inc.
    Inventors: Paul Slusarewicz, Jessica Baker Flechtner, Sunil Mehta, Kenya Prince-Cohane, Sofija Andjelic, Brian H. Barber
  • Publication number: 20050214312
    Abstract: Hybrid antigens comprising at least one antigenic domain, at least one heat shock protein binding domain, and at least one improved peptide linker there between are described which are useful for the induction of an immune response to the antigenic domain when administered alone or in a complex with at least one heat shock protein. The hybrid antigens and complexes can be used to treat infectious diseases and cancers that express an antigen of the antigenic domain.
    Type: Application
    Filed: April 8, 2004
    Publication date: September 29, 2005
    Inventors: Jessica Flechtner, Kenya Prince-Cohane, Sunil Mehta, Paul Slusarewicz, Sofija Andjelic, Brian Barber
  • Publication number: 20050202033
    Abstract: Hybrid antigens comprising an antigenic domain and improved heat shock protein binding domains are described which are useful for the induction of an immune response to the antigenic domain and thus can be used to treat infectious diseases and cancers that express an antigen of the antigenic domain.
    Type: Application
    Filed: February 12, 2004
    Publication date: September 15, 2005
    Inventors: Jessica Flechtner, Kenya Prince-Cohane, Sunil Mehta, Paul Slusarewicz, Sofija Andjelic, Brian Barber